Wednesday 23 January 2019 ,
Wednesday 23 January 2019 ,
Latest News
  • Seventh span of Padma Bridge installed
  • 6 members of a family among 7 killed in Laxmipur road crash
  • Rohingya plight peaks
  • HC ‘ashamed’ over Tabligh Jamaat split
  • Field-level workers push for reshuffle in BNP leadership
  • All Bengali ‘refugees’ will be given citizenship
  • Expedite project work, ensure quality: PM
  • PM orders expediting project works maintaining quality
7 January, 2019 00:00 00 AM

FDA approves Vaxelis Pediatric Hexavalent combination vaccine

drugs.com
FDA approves Vaxelis Pediatric Hexavalent combination vaccine

The U.S. Food and Drug Administration has approved Vaxelis™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate [Meningococcal Protein Conjugate] and Hepatitis B [Recombinant] Vaccine) for use in children from 6 weeks through 4 years of age (prior to the 5th birthday). Vaxelis was developed as part of a joint-partnership between Sanofi and Merck, known as MSD outside the United States and Canada.

Indication for Vaxelis

Vaxelis is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b. Vaxelis is approved for use as a 3-dose series in children 6 weeks through 4 years of age (prior to the 5th birthday).

Select safety information for Vaxelis

Vaxelis is contraindicated in children with a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of Vaxelis, any ingredient of Vaxelis, or any other diphtheria toxoid, tetanus toxoid, pertussis-containing vaccine, inactivated poliovirus vaccine, hepatitis B vaccine, or

H. influenzae type b vaccine.

Do not administer Vaxelis to anyone with a history of encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures), within 7 days of a pertussis-containing vaccine, that is not attributable to another identifiable cause.

Do not administer Vaxelis to anyone with a history of progressive neurologic disorder until a treatment regimen has been established and the condition has stabilized.

Vaccination with Vaxelis may not protect all individuals.

Carefully consider benefits and risks before administering Vaxelis to persons with a history of:

fever of ≥40.5°C  (≥105°F), hypotonic-hyporesponsive episode (HHE) or persistent, inconsolable crying lasting ≥3 hours within 48 hours after a previous pertussis-containing vaccine.

seizures within 3 days after a previous pertussis-containing vaccine.

If Guillain-Barré syndrome occurred within 6 weeks of receipt of a prior vaccine containing tetanus toxoid, the risk for Guillain-Barré syndrome may be increased following Vaxelis.

Apnea following intramuscular vaccination has been observed in some infants born prematurely. The decision about when to administer an intramuscular vaccine, including Vaxelis, to an infant born prematurely should be based on considerations of the individual infant’s medical status and the potential benefits and possible risks of vaccination.

Urine antigen detection may not have definitive diagnostic value in suspected H. influenza type b disease following vaccination with Vaxelis.

The solicited adverse reactions following any dose were irritability (≥55%), crying (≥45%), injection site pain (≥44%), somnolence (≥40%), injection site erythema (≥25%), decreased appetite (≥23%), fever ≥38.0°C (≥19%), injection site swelling (≥18%), and vomiting (≥9%).

Please see the full Prescribing Information for Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate [Meningococcal Protein Conjugate] and Hepatitis B [Recombinant] Vaccine).

Dosage and administration for Vaxelis

The 3-dose immunization series consists of a 0.5 mL intramuscular injection, administered at 2, 4, and 6 months of age.

A 3-dose series of Vaxelis does not constitute a primary immunization series against pertussis; an additional dose of pertussis-containing vaccine is needed to complete the primary series.

 

Comments

Most Viewed
Digital Edition
More story
From the Editor

From the Editor

Infections are invasion and multiplication of micro-organisms in body tissues, especially that causing local cellular injury due to competitive metabolism,…
Infectious diseases

Infectious diseases

Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly,…
FAQ on streptococcal infections

FAQ on streptococcal infections

Group B streptococcus (group B strep) is a type of bacteria that causes illness in newborn babies, pregnant women, the elderly, and adults with other…
Viral infections

Viral infections

A viral infection is any type of infection that is caused by a virus, which is even smaller than bacteria and is encapsulated by a protective coating…
Respiratory tract infections

Respiratory tract infections

Respiratory tract infections are infections that occur anywhere in the respiratory tract. Parts of the body that we use in the breathing process are referred…
How to treat and prevent cold sores on your lips

How to treat and prevent cold sores on your lips

If you've ever looked in the mirror and saw a pimple-looking dot on your mouth that hurts a lot, you're not alone — but it's not always…
What do the different poop colors and shapes mean?

What do the different poop colors and shapes mean?

CATHY WONG    Although you may not pay much attention to your stools, looking at them regularly can help you pick up on variations in color,…
Splint for burn patient

Splint for burn patient

Burn disaster is a common disaster in Bangladesh. Each year, approximately 265,000 deaths occur due to burns on a global scale. In Bangladesh, around…
Type 2 diabetes before 40 tied to mental illness hospitalizations

Type 2 diabetes before 40 tied to mental illness hospitalizations

People who develop type 2 diabetes before they turn 40 are twice as likely to be hospitalized for mental illness as those who develop the blood sugar…
AHA: Hookah smoking trendy, despite evidence of health risks

AHA: Hookah smoking trendy, despite evidence of health risks

While cigarette smoking has hit an all-time low, another form of tobacco use is rising in popularity -- hookah smoking -- and researchers are concerned…
New birth control skin patch being developed

New birth control skin patch being developed

A skin patch that provides a month's worth of birth control for women is being developed by U.S. researchers. The patch, which can be pressed into…
FDA approves expanded use of Adacel (Tdap) vaccine for repeat vaccination

FDA approves expanded use of Adacel (Tdap) vaccine for repeat vaccination

The U.S. Food and Drug Administration has approved the expanded use of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting